3 studies found for:    EPAS1
Show Display Options
Rank Status Study
1 Recruiting Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
Conditions: Major Depressive Disorder;   Obesity;   Inflammation
Interventions: Other: Placebo;   Drug: EPA 1 g/day;   Drug: EPA 2 g/day;   Drug: EPA 4 g/day
2 Active, not recruiting
Has Results
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Conditions: Childhood Cerebral Anaplastic Astrocytoma;   Childhood Oligodendroglioma;   Childhood Spinal Cord Neoplasm;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma
Interventions: Biological: Bevacizumab;   Radiation: Fludeoxyglucose F-18;   Drug: Irinotecan Hydrochloride
3 Not yet recruiting Albumin in Cardiac Surgery
Condition: C.Surgical Procedure; Cardiac
Interventions: Drug: Albumin solution;   Drug: Ringers acetate solution

Indicates status has not been verified in more than two years